{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:41:00Z","timestamp":1792518060429,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"DOI":"10.1007\/s10067-026-08475-3","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T17:09:07Z","timestamp":1792256947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between post-intravenous immunoglobulin hypothermia and lower receipt of second-line therapy in Kawasaki disease: a single-center retrospective cohort study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1473-6564","authenticated-orcid":false,"given":"Masayuki","family":"Arimatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9266-7811","authenticated-orcid":false,"given":"Shintaro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongsun","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"8475_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","volume":"364","author":"JC Burns","year":"2004","unstructured":"Burns JC, Glod\u00e9 MP (2004) Kawasaki syndrome. Lancet 364:533\u2013544. https:\/\/doi.org\/10.1016\/S0140-6736(04)16814-1","journal-title":"Lancet"},{"key":"8475_CR2","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"PN Jone","year":"2024","unstructured":"Jone PN, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y et al (2024) Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association. Circulation 150:e481\u2013e500. https:\/\/doi.org\/10.1161\/CIR.0000000000001295","journal-title":"Circulation"},{"key":"8475_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/art.42041","volume":"74","author":"M Gorelik","year":"2022","unstructured":"Gorelik M, Chung SA, Ardalan K, Binstadt BA, Friedman K, Hayward K, Imundo LF, Lapidus SK, Kim S, Son MB, Sule S, Tremoulet AH, Van Mater H, Yildirim\u2010Toruner C, Langford CA, Maz M, Abril A, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Merkel PA, Rhee RL, Seo P, Stone JH, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot M, Lin YC, Springer JM, Turgunbaev M, Villa\u2010Forte A, Turner AS, Mustafa RA (2022) 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of Kawasaki disease. Arthritis Rheumatol 74:586\u2013596. https:\/\/doi.org\/10.1002\/art.42041","journal-title":"Arthritis Rheumatol"},{"key":"8475_CR4","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927\u2013e999. https:\/\/doi.org\/10.1161\/CIR.0000000000000484","journal-title":"Circulation"},{"key":"8475_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/ped.13809","volume":"61","author":"N Makino","year":"2019","unstructured":"Makino N, Nakamura Y, Yashiro M, Kosami K, Matsubara Y, Ae R et al (2019) Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015\u20132016. Pediatr Int 61:397\u2013403. https:\/\/doi.org\/10.1111\/ped.13809","journal-title":"Pediatr Int"},{"key":"8475_CR6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-059175","volume":"151","author":"Y Kuniyoshi","year":"2023","unstructured":"Kuniyoshi Y, Tsujimoto Y, Banno M, Taito S, Ariie T, Takahashi N et al (2023) Prediction models for intravenous immunoglobulin resistance in Kawasaki disease: a meta-analysis. Pediatrics 151:e2022059175. https:\/\/doi.org\/10.1542\/peds.2022-059175","journal-title":"Pediatrics"},{"key":"8475_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/INF.0000000000000891","volume":"34","author":"P Jaggi","year":"2015","unstructured":"Jaggi P, Wang W, Dvorchik I, Printz B, Berry E, Kovalchin JP et al (2015) Patterns of fever in children after primary treatment for Kawasaki disease. Pediatr Infect Dis J 34:1315\u20131318. https:\/\/doi.org\/10.1097\/INF.0000000000000891","journal-title":"Pediatr Infect Dis J"},{"key":"8475_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","volume":"62","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Ayusawa M, Suzuki H, Abe J, Ito S, Kato T et al (2020) Revision of diagnostic guidelines for Kawasaki disease. Pediatr Int 62:1135\u20131138","journal-title":"Pediatr Int"},{"key":"8475_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y et al (2020) JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J 84:1348\u20131407. https:\/\/doi.org\/10.1253\/circj.CJ-19-1094","journal-title":"Circ J"},{"key":"8475_CR10","doi-asserted-by":"publisher","unstructured":"Miura M, Ayusawa M, Fukazawa R, Hamada H, Ikeda S, Ito S et al (2021) Guidelines for medical treatment of acute Kawasaki disease (2020 revised version). J Pediatr Cardiol Card Surg 5:41\u201373. https:\/\/doi.org\/10.24509\/jpccs.0501G1","DOI":"10.24509\/jpccs.0501G1"},{"key":"8475_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0030","volume":"172","author":"M Miura","year":"2018","unstructured":"Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N et al (2018) Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr 172:e180030. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0030","journal-title":"JAMA Pediatr"},{"key":"8475_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226985","volume":"13","author":"S Kishimoto","year":"2024","unstructured":"Kishimoto S, Fujimoto T, Ihara K (2024) Severity of acute Kawasaki disease can be predicted by evaluating the body temperature at the completion of an initial immunoglobulin treatment. J Clin Med 13:6985. https:\/\/doi.org\/10.3390\/jcm13226985","journal-title":"J Clin Med"},{"key":"8475_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jpeds.2016.08.060","volume":"179","author":"ML Downie","year":"2016","unstructured":"Downie ML, Manlhiot C, Latino GA, Collins TH, Chahal N, Yeung RS et al (2016) Variability in response to intravenous immunoglobulin in the treatment of Kawasaki disease. J Pediatr 179:124-130.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.08.060","journal-title":"J Pediatr"},{"key":"8475_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpeds.2021.05.020","volume":"236","author":"A Tanaka","year":"2021","unstructured":"Tanaka A, Inoue M, Hoshina T, Koga H (2021) Correlation of coronary artery abnormalities with fever pattern in patients with Kawasaki disease. J Pediatr 236:95\u2013100. https:\/\/doi.org\/10.1016\/j.jpeds.2021.05.020","journal-title":"J Pediatr"},{"key":"8475_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014884.pub2","volume":"1","author":"C Broderick","year":"2023","unstructured":"Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T (2023) Intravenous immunoglobulin for the treatment of Kawasaki disease. Cochrane Database Syst Rev 1:CD014884. https:\/\/doi.org\/10.1002\/14651858.CD014884.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"8475_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.3063","volume":"8","author":"HC Kuo","year":"2025","unstructured":"Kuo HC, Lin MC, Kao CC, Weng KP, Ding Y, Han Z et al (2025) Intravenous immunoglobulin alone for coronary artery lesion treatment of Kawasaki disease: a randomized clinical trial. JAMA Netw Open 8:e253063. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.3063","journal-title":"JAMA Netw Open"},{"key":"8475_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03395-9","volume":"15","author":"D Sajiki","year":"2025","unstructured":"Sajiki D, Nishio N, Kato T, Hirao T, Suzuki K, Go K et al (2025) Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study. Sci Rep 15:18502. https:\/\/doi.org\/10.1038\/s41598-025-03395-9","journal-title":"Sci Rep"},{"key":"8475_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13409","volume":"51","author":"HH Liu","year":"2021","unstructured":"Liu HH, Qiu Z, Fan GZ, Jiang Q, Li RX, Chen WX et al (2021) Assessment of coronary artery abnormalities and variability of Z-score calculation in the acute episode of Kawasaki disease: a retrospective study from China. Eur J Clin Invest 51:e13409. https:\/\/doi.org\/10.1111\/eci.13409","journal-title":"Eur J Clin Invest"},{"key":"8475_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-024-05035-z","volume":"24","author":"YT Lim","year":"2024","unstructured":"Lim YT, Kwon JE, Kim YH (2024) Evaluating the performance of Egami, Kobayashi and Sano scores in predicting IVIG resistance in infant Kawasaki disease. BMC Pediatr 24:606. https:\/\/doi.org\/10.1186\/s12887-024-05035-z","journal-title":"BMC Pediatr"},{"key":"8475_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59972-7","volume":"10","author":"M Piram","year":"2020","unstructured":"Piram M, Darce Bello M, Tellier S, Di Filippo S, Boralevi F, Madhi F et al (2020) Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease. Sci Rep 10:3125. https:\/\/doi.org\/10.1038\/s41598-020-59972-7","journal-title":"Sci Rep"},{"key":"8475_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17030278","volume":"17","author":"D Rigante","year":"2016","unstructured":"Rigante D, Andreozzi L, Fastiggi M, Bracci B, Natale MF, Esposito S (2016) Critical overview of the risk scoring systems to predict non-responsiveness to intravenous immunoglobulin in Kawasaki syndrome. Int J Mol Sci 17:278. https:\/\/doi.org\/10.3390\/ijms17030278","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08475-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:06Z","timestamp":1792515726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08475-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":21,"alternative-id":["8475"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08475-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Matsudo City General Hospital (approval no. R6-27) and was conducted in accordance with the Declaration of Helsinki and relevant institutional guidelines. An opt-out consent process was adopted in accordance with institutional regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}